Cardiff Lexington Corporation (CDIX)
Cardiff Lexington Corporation
3753 Howard Hughes Parkway
Suite 200
Las Vegas, NV 89169
United States
844 628 2100
https://www.cardifflexington.com
Sector(es): Financial Services
Industria: Asset Management
Empleados a tiempo completo: 13
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Daniel R. Thompson | Chairman of the Board & Secretary | 610k | N/D | 1949 |
| Mr. Matthew T. Shafer | Senior VP, CFO & Treasurer | N/D | N/D | 1971 |
| Dr. Kevin Fitzgerald M.D. | Managing Director of Nova Ortho & Spine | N/D | N/D | N/D |
Descripción
Cardiff Lexington Corporation, together with its subsidiaries, operates in health care business in the United States. The company Healthcare, and Real Estate segments. It also provides tax resolution service to individuals and companies that have federal and state tax liabilities; and a range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. In addition, the company engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Las Vegas, Nevada.
Gestión corporativa
La calificación ISS Governance QuickScore de Cardiff Lexington Corporation a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
